Heart failure hospitalization following surgical or transcatheter aortic valve implantation in low-risk aortic stenosis.

Helena LópezVictoria VilaltaJulio Farjat-PasosElena Ferrer-SistachSiamak MohammadiClaudia EscabiaDimitri KalavrouziotisHelena RestaAndrea BorrellasEric DumontXavier CarrilloJean-Michel ParadisEduard Fernández-NofreríasVictoria DelgadoJosep Rodés-CabauAntoni Bayes-Genis

Published in: ESC heart failure (2024)

In low-risk AS, SU-SAVR is associated with a higher risk of HFH and all-cause mortality compared to TAVI. In patients with severe AS candidate to SU-SAVR or TAVI, TAVI may be the preferred intervention.

Keyphrases

transcatheter aortic valve implantation
aortic stenosis
aortic valve replacement
transcatheter aortic valve replacement
aortic valve
left ventricular
ejection fraction
heart failure
randomized controlled trial
coronary artery disease
cardiac resynchronization therapy
early onset
acute heart failure